Invega sustenna and Lower limb fracture - a phase IV clinical study of FDA data

Summary:

No or too few reports are found.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

On Sep, 25, 2023

No or too few reports are found.

What is Invega Sustenna?

Invega sustenna has active ingredients of paliperidone palmitate. It is used in schizophrenia. Currently, eHealthMe is studying from 22,118 Invega sustenna users.

What is Lower Limb Fracture?

Lower limb fracture is found to be associated with 1,696 drugs and 847 conditions by eHealthMe. Currently, we are studying 20,006 people who have Lower limb fracture.

Do you take Invega sustenna and have Lower limb fracture?

Check whether Lower limb fracture is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Lower limb fracture and when was it recovered:

Lower limb fracture in Invega sustenna

Expand to all the drugs that have ingredients of paliperidone palmitate:

Lower limb fracture and drugs with ingredients of paliperidone palmitate

Alternative drugs to, pros and cons of Invega sustenna:

Invega sustenna (22,118 reports)

Browse all side effects of Invega sustenna:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on paliperidone palmitate (the active ingredients of Invega sustenna) and Invega sustenna (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.